Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Efficacy of standardized extract of Hibiscus sabdariffa L. (Malvaceae) in improving iron status of adults in malaria endemic area: A randomized controlled trial.

Peter EL, Rumisha SF, Mashoto KO, Minzi OM, Mfinanga S.

J Ethnopharmacol. 2017 Sep 14;209:288-293. doi: 10.1016/j.jep.2017.07.037. Epub 2017 Jul 26.

PMID:
28755971
2.

Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.

Mutagonda RF, Kamuhabwa AAR, Minzi OMS, Massawe SN, Asghar M, Homann MV, Färnert A, Aklillu E.

Malar J. 2017 Jul 3;16(1):267. doi: 10.1186/s12936-017-1914-9.

3.

Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.

Mutagonda RF, Kamuhabwa AA, Minzi OM, Massawe SN, Maganda BA, Aklillu E.

Malar J. 2016 May 13;15(1):278. doi: 10.1186/s12936-016-1327-1.

4.

Safety Profile of Artemether-Lumefantrine: A Cohort Event Monitoring Study in Public Health Facilities in Tanzania.

Mssusa AK, Fimbo AM, Nkayamba AF, Irunde HF, Sillo HB, Shewiyo DH, Hill G, Minzi OM.

Clin Drug Investig. 2016 May;36(5):401-11. doi: 10.1007/s40261-016-0385-z.

PMID:
26951203
5.

CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.

Maganda BA, Minzi OM, Ngaimisi E, Kamuhabwa AA, Aklillu E.

Pharmacogenomics J. 2016 Feb;16(1):88-95. doi: 10.1038/tpj.2015.37. Epub 2015 May 12.

PMID:
25963334
6.
7.

Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.

Marwa KJ, Schmidt T, Sjögren M, Minzi OM, Kamugisha E, Swedberg G.

Malar J. 2014 Nov 3;13:420. doi: 10.1186/1475-2875-13-420.

8.

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment.

Ngaimisi E, Minzi O, Mugusi S, Sasi P, Riedel KD, Suda A, Ueda N, Bakari M, Janabi M, Mugusi F, Bertilsson L, Burhenne J, Aklillu E, Diczfalusy U.

J Antimicrob Chemother. 2014 Dec;69(12):3311-9. doi: 10.1093/jac/dku286. Epub 2014 Aug 4.

PMID:
25096076
9.
10.

Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy.

Maganda BA, Minzi OM, Kamuhabwa AA, Ngasala B, Sasi PG.

Malar J. 2014 May 30;13:205. doi: 10.1186/1475-2875-13-205.

11.
12.

Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in sub-Saharan Africa.

Machado LR, Bowdrey J, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Yimer G, Amogne W, Mugusi S, Janabi M, Aderaye G, Mugusi F, Viskaduraki M, Aklillu E, Hollox EJ.

PLoS One. 2013 Nov 8;8(11):e78165. doi: 10.1371/journal.pone.0078165. eCollection 2013.

13.

CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans.

Aklillu E, Odenthal-Hesse L, Bowdrey J, Habtewold A, Ngaimisi E, Yimer G, Amogne W, Mugusi S, Minzi O, Makonnen E, Janabi M, Mugusi F, Aderaye G, Hardwick R, Fu B, Viskaduraki M, Yang F, Hollox EJ.

BMC Infect Dis. 2013 Nov 12;13:536. doi: 10.1186/1471-2334-13-536.

14.

Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations.

Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Mugusi S, Amogne W, Yimer G, Riedel KD, Janabi M, Aderaye G, Mugusi F, Bertilsson L, Aklillu E, Burhenne J.

PLoS One. 2013 Jul 5;8(7):e67946. doi: 10.1371/journal.pone.0067946. Print 2013.

15.
16.

Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product.

Minzi OM, Marealle IA, Shekalaghe S, Juma O, Ngaimisi E, Chemba M, Rutaihwa M, Abdulla S, Sasi P.

Malar J. 2013 May 30;12:174. doi: 10.1186/1475-2875-12-174.

17.

A fast and reliable reversed phase high performance liquid chromatography method for simultaneous determination of selected anti-retroviral and lumefantrine in human plasma.

Maganda B, Heudi O, Cortinovis A, Picard F, Kretz O, Minzi O.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Mar 1;919-920:52-60. doi: 10.1016/j.jchromb.2013.01.009. Epub 2013 Jan 19.

PMID:
23411019
18.

Application of basic pharmacology and dispensing practice of antibiotics in accredited drug-dispensing outlets in Tanzania.

Minzi O, Manyilizu V.

Drug Healthc Patient Saf. 2013;5:5-11. doi: 10.2147/DHPS.S36409. Epub 2013 Jan 30.

19.

Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania.

Joseph D, Kabanywanyi AM, Hulser R, Premji Z, Minzi OM, Mugittu K.

Malar J. 2013 Feb 11;12:60. doi: 10.1186/1475-2875-12-60.

20.

β-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans.

Hardwick RJ, Amogne W, Mugusi S, Yimer G, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Janabi M, Machado LR, Viskaduraki M, Mugusi F, Aderaye G, Lindquist L, Hollox EJ, Aklillu E.

J Infect Dis. 2012 Oct 1;206(7):1012-9. doi: 10.1093/infdis/jis448. Epub 2012 Jul 26.

PMID:
22837491

Supplemental Content

Support Center